Shares of Novacyt SA (LON:NCYT) traded up 12.5% during mid-day trading on Monday . The company traded as high as GBX 9 ($0.12) and last traded at GBX 9 ($0.12), 5,000 shares traded hands during mid-day trading. The stock had previously closed at GBX 8 ($0.10).
The company has a debt-to-equity ratio of 47.02, a quick ratio of 0.37 and a current ratio of 0.83. The firm has a market capitalization of $3.78 million and a P/E ratio of -0.39. The business has a fifty day moving average of GBX 7.14 and a 200-day moving average of GBX 9.61.
Novacyt Company Profile (LON:NCYT)
Novacyt SA develops and sells diagnostic products for cancer and infectious diseases. The company's diagnostic products are used in liquid based cytology, oncology, microbiology, haematology, and serology testing. It offers NovaPrep, a liquid based cytology solution that is utilized in the diagnosis of cervical cancer; and clinical laboratory testing services to clinicians, healthcare providers, and patients.
Featured Article: How Buying a Call Option Works
Receive News & Ratings for Novacyt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novacyt and related companies with MarketBeat.com's FREE daily email newsletter.